indication for semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough the treatment of obesity 💊 NEW ORAL WEGOVY® (Semaglutide)

In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux

Ayrca yaplan kk lekli aratrmalar L carnitin takviyelerinin kilo kaybn hzlandrmad ynnde sonulara sahip

The good news is the idea that GLP-1s melt muscle doesnt hold up

Or Ozempic, because its getting so much hype